These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22920393)

  • 1. Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.
    Liu Q; Jamba M; Patrick C; Padmanabhan S; Brennan MD
    Pharmacogenomics; 2012 Aug; 13(11):1227-37. PubMed ID: 22920393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.
    Ramsey TL; Liu Q; Massey BW; Brennan MD
    Schizophr Res; 2013 Sep; 149(1-3):21-5. PubMed ID: 23886675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia.
    Zhang JP; Lencz T; Geisler S; DeRosse P; Bromet EJ; Malhotra AK
    Schizophr Res; 2013 May; 146(1-3):285-8. PubMed ID: 23433505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.
    Yu H; Yan H; Wang L; Li J; Tan L; Deng W; Chen Q; Yang G; Zhang F; Lu T; Yang J; Li K; Lv L; Tan Q; Zhang H; Xiao X; Li M; Ma X; Yang F; Li L; Wang C; Li T; Zhang D; Yue W;
    Lancet Psychiatry; 2018 Apr; 5(4):327-338. PubMed ID: 29503163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
    Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
    Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.
    Ramsey TL; Brennan MD
    Schizophr Res; 2014 Dec; 160(1-3):73-9. PubMed ID: 25449714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.
    Ramsey TL; Meltzer HY; Brock GN; Mehrotra B; Jayathilake K; Bobo WV; Brennan MD
    Pharmacogenomics; 2011 Apr; 12(4):471-80. PubMed ID: 21521020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.
    Campbell DB; Ebert PJ; Skelly T; Stroup TS; Lieberman J; Levitt P; Sullivan PF
    Biol Psychiatry; 2008 Jan; 63(1):32-41. PubMed ID: 17588543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia.
    Apud JA; Zhang F; Decot H; Bigos KL; Weinberger DR
    Am J Psychiatry; 2012 Jul; 169(7):725-34. PubMed ID: 22706279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.
    Schuhmacher A; Becker T; Rujescu D; Quednow BB; Lennertz L; Wagner M; Benninghoff J; Rietschel M; Häfner H; Franke P; Wölwer W; Gaebel W; Maier W; Mössner R
    J Psychiatr Res; 2012 Aug; 46(8):1073-80. PubMed ID: 22655589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
    Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA
    J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.
    Bishop JR; Reilly JL; Harris MS; Patel SR; Kittles R; Badner JA; Prasad KM; Nimgaonkar VL; Keshavan MS; Sweeney JA
    Psychopharmacology (Berl); 2015 Jan; 232(1):145-54. PubMed ID: 25096017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.
    Need AC; Keefe RS; Ge D; Grossman I; Dickson S; McEvoy JP; Goldstein DB
    Eur J Hum Genet; 2009 Jul; 17(7):946-57. PubMed ID: 19156168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.
    Alkelai A; Greenbaum L; Rigbi A; Kanyas K; Lerer B
    Psychopharmacology (Berl); 2009 Oct; 206(3):491-9. PubMed ID: 19680635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.
    Crisafulli C; Chiesa A; Han C; Lee SJ; Park MH; Balzarro B; Andrisano C; Patkar AA; Pae CU; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2012 Apr; 262(3):199-205. PubMed ID: 22120873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage.
    Hettige NC; de Moraes GH; Kennedy JL; De Luca V
    Pharmacogenomics; 2016 Feb; 17(3):199-208. PubMed ID: 26780210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
    Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
    Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
    Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
    Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.